← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1977Last known activity
Jan 1, 2024
Timeline
1940s
- Jan 1, 1948
State University of New York— Founded
Drugs by trial phase (80 distinct, 71 trials)
Phase 4 (31 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (22 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Alcoholism
- Alcohol-Related Disorders
- Anxiety Disorders
- Asthma
- Attention Deficit Disorder with Hyperactivity
- Autoimmune Diseases
- Autoimmune Diseases of the Nervous System
- Back Pain
- Behavior, Addictive
- Bipolar Disorder
- Body Weight
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cardiovascular Diseases
- Chronic Pain
- Contracture
- Coronary Disease
- Death, Sudden
- Death, Sudden, Cardiac
- Delirium
- Demyelinating Autoimmune Diseases, CNS
- Depression
- Depressive Disorder
- Diabetes Mellitus, Type 2
- Disease
- Dupuytren Contracture
- Emergence Delirium
- Fatigue
- Fibromyalgia
- Head and Neck Neoplasms
- Heart Diseases
- Heart Failure
- Hematuria
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hyperkinesis
- Hypertension
- Hypogonadism
- Intractable Pain
- Kidney Diseases
- Kidney Failure, Chronic
- Liver Diseases
- Low Back Pain
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Mental Disorders
- Multiple Sclerosis
- Myelitis
- Myelitis, Transverse
- Myocardial Infarction
- Myocardial Ischemia
- Myofascial Pain Syndromes
- Myopia
- Nervous System Diseases
- Neuromyelitis Optica
- Opioid-Related Disorders
- Phobia, Social
- Pneumonia
- Polyuria
- Postoperative Pain
- Problem Behavior
- Psychotic Disorders
- Rabies
- Renal Insufficiency, Chronic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinopathy of Prematurity
- Schizophrenia
- Sclerosis
- Sepsis
- Sleep Initiation and Maintenance Disorders
- Stress Disorders, Post-Traumatic
- Substance-Related Disorders
- Syndrome
- Tobacco Use Disorder
- Urinary Bladder Neoplasms
- Ventricular Fibrillation
- Weight Gain
Recent trials (50)
- NCT06029530CollaboratorPhase 1Jan 1, 2024
- NCT05505292Lead sponsorPhase 4Sep 22, 2022
- NCT05505292Overall official - principal investigatorPhase 4Sep 22, 2022
- NCT05505292Reponsible party - principal investigatorPhase 4Sep 22, 2022
- NCT04448535Lead sponsorN/AJul 31, 2020
- NCT04448535Reponsible party - principal investigatorN/AJul 31, 2020
- NCT03544827Reponsible party - principal investigatorPhase 4May 21, 2018
- NCT03544827Overall official - principal investigatorPhase 4May 21, 2018
- NCT03544827Lead sponsorPhase 4May 21, 2018
- NCT03139279Lead sponsorPhase 4May 5, 2017
- NCT02927405Lead sponsorPhase 4May 1, 2017
- NCT03066440Lead sponsorN/AApr 1, 2017
- NCT03158142Lead sponsorPhase 4Mar 15, 2017
- NCT02981459Lead sponsorPhase 4Jan 1, 2017
- NCT02725164Lead sponsorN/AApr 12, 2016
Details
- Founded
- Albany, NY, US Jan 1, 1948
- Last known activity
- Jan 1, 2024